• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过[O]O一次性使用和[F]CHCOOF标记剂相结合提高4-硼代-2-[F]氟-L-苯丙氨酸合成的稳定性和实用性。

Improved Stability and Practicality for Synthesis of 4-Borono-2-[F]fluoro-l-phenylalanine by Combination of [O]O Single-Use and [F]CHCOOF Labeling Agents.

作者信息

Naka Sadahiro, Watanabe Toshimitsu, Kanai Yasukazu, Watabe Tadashi, Tatsumi Mitsuaki, Kato Hiroki, Shimosegawa Eku, Hatazawa Jun

机构信息

Department of Nuclear Medicine and Tracer Kinetics, Graduate School of Medicine, Osaka University, 2-2, Yamadaoka, Suita, Osaka 565-0871 Japan.

Department of Radiology, Osaka University Hospital, 2-15, Yamadaoka, Suita, Osaka 565-0871 Japan.

出版信息

Nucl Med Mol Imaging. 2022 Apr;56(2):86-95. doi: 10.1007/s13139-021-00719-1. Epub 2022 Feb 8.

DOI:10.1007/s13139-021-00719-1
PMID:35449598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8976863/
Abstract

PURPOSE

4-Borono-2-[F]fluoro-l-phenylalanine ([F]FBPA) synthesized with [F]F, produced using the O(p, n)F reaction, has been reported for increasing radioactivity. However, a dedicated system and complex procedure is required to reuse the costly [O]O gas; also, the use of [F]F as a labeling agent reduces the labeling rate and radiochemical purity. We developed a stable and practical method for [F]FBPA synthesis by combining [F]F, produced using a [O]O single-use system, and a [F]CHCOOF labeling agent.

METHODS

The produced [F]F was optimized, and then [F]FBPA was synthesized. For passivation of the target box, 0.5% F was pre-irradiated in argon. Gaseous products were discarded; the target box was filled with [O]O gas, and then irradiated (first irradiation). Then, the [O]O gas was discarded, 0.05-0.08% F in argon was fed into the target box, and it was again irradiated (second irradiation). The [F]F obtained after this was passed through a CHCOONa column, converting it into the [F]CHCOOF labeling agent, which was then used for [F]FBPA synthesis.

RESULTS

The mean amount of as-obtained [F]F was 55.0 ± 3.3 GBq and that of as-obtained [F]CHCOOF was 21.6 ± 1.4 GBq after the bombardment. The radioactivity and the radiochemical yield based on [F]F of [F]FBPA were 4.72 ± 0.34 GBq and 12.2 ± 0.1%, respectively. The radiochemical purity and molar activity were 99.3 ± 0.1% and 231 ± 22 GBq/mmol, respectively.

CONCLUSION

We developed a method for [F]FBPA production, which is more stable and practical compared with the method using [O]O gas-recycling and [F]F labeling agent.

摘要

目的

已报道用[F]F通过O(p, n)F反应合成的4-硼-2-[F]氟-L-苯丙氨酸([F]FBPA)可提高放射性。然而,要重复使用昂贵的[O]O气体需要专用系统和复杂程序;此外,使用[F]F作为标记剂会降低标记率和放射化学纯度。我们通过将使用一次性[O]O系统产生的[F]F与[F]CHCOOF标记剂相结合,开发了一种稳定且实用的[F]FBPA合成方法。

方法

对产生的[F]F进行优化,然后合成[F]FBPA。为使靶盒钝化,在氩气中预辐照0.5%的F。气态产物被丢弃;靶盒充入[O]O气体,然后进行辐照(第一次辐照)。然后,丢弃[O]O气体,将氩气中0.05 - 0.08%的F通入靶盒,并再次进行辐照(第二次辐照)。之后得到的[F]F通过CHCOONa柱,转化为[F]CHCOOF标记剂,然后用于[F]FBPA的合成。

结果

轰击后得到的[F]F的平均量为55.0±3.3 GBq,得到的[F]CHCOOF的平均量为21.6±1.4 GBq。基于[F]F的[F]FBPA的放射性和放射化学产率分别为4.72±0.34 GBq和12.2±0.1%。放射化学纯度和摩尔活度分别为99.3±0.1%和231±22 GBq/mmol。

结论

我们开发了一种[F]FBPA的生产方法,与使用[O]O气体循环和[F]F标记剂的方法相比,该方法更稳定、更实用。

相似文献

1
Improved Stability and Practicality for Synthesis of 4-Borono-2-[F]fluoro-l-phenylalanine by Combination of [O]O Single-Use and [F]CHCOOF Labeling Agents.通过[O]O一次性使用和[F]CHCOOF标记剂相结合提高4-硼代-2-[F]氟-L-苯丙氨酸合成的稳定性和实用性。
Nucl Med Mol Imaging. 2022 Apr;56(2):86-95. doi: 10.1007/s13139-021-00719-1. Epub 2022 Feb 8.
2
Reliable radiosynthesis of 4-[B]borono-2-[F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis.用于硼中子俘获治疗导向诊断的具有质量保证的4-[硼]硼酸-2-[氟]氟-L-苯丙氨酸的可靠放射性合成。
Ann Nucl Med. 2018 Aug;32(7):463-473. doi: 10.1007/s12149-018-1268-6. Epub 2018 Jun 5.
3
Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.评估4-硼-2-¹⁸F-氟-L-苯丙氨酸-果糖作为荷胶质瘤大鼠模型中硼中子俘获疗法探针的性能。
J Nucl Med. 2004 Feb;45(2):302-8.
4
Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG.使用改良的亲核型通用电气TRACERlab FXFDG进行[¹⁸F]FBPA的自动化亲电放射性合成。
Appl Radiat Isot. 2015 Oct;104:124-7. doi: 10.1016/j.apradiso.2015.06.034. Epub 2015 Jul 2.
5
4-Borono-2-F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research.用于硼中子俘获疗法导向诊断的4-硼-2-氟-L-苯丙氨酸PET:二十五年研究综述
Ann Nucl Med. 2019 Apr;33(4):223-236. doi: 10.1007/s12149-019-01347-8. Epub 2019 Feb 28.
6
Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[F]fluorophenylalanine ([F]FBPA).无载体添加和载体添加的 4-硼基-2-[F]氟苯丙氨酸([F]FBPA)的合成与生物性质比较。
Nucl Med Biol. 2023 Jan-Feb;116-117:108313. doi: 10.1016/j.nucmedbio.2022.108313. Epub 2022 Dec 30.
7
Evaluation of D-isomers of 4-borono-2-F-fluoro-phenylalanine and O-C-methyl-tyrosine as brain tumor imaging agents: a comparative PET study with their L-isomers in rat brain glioma.4-硼-2-氟苯丙氨酸和O-碳-甲基酪氨酸的D-异构体作为脑肿瘤显像剂的评估:在大鼠脑胶质瘤中与其L-异构体的PET对比研究
EJNMMI Res. 2018 Jun 13;8(1):47. doi: 10.1186/s13550-018-0404-6.
8
Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy.超声诱导血脑屏障破坏后 18F-FBPA-Fr 的药代动力学分析和摄取,以潜在增强硼中子俘获治疗的硼递呈。
J Nucl Med. 2014 Apr;55(4):616-21. doi: 10.2967/jnumed.113.125716. Epub 2014 Feb 13.
9
Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.用正电子发射断层扫描(PET)研究4-硼-2-[¹⁸F]氟-L-苯丙氨酸在散发性及与神经纤维瘤病2相关的神经鞘瘤和脑膜瘤中的摄取情况。
Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):87-94. doi: 10.1007/s00259-006-0154-y. Epub 2006 Jul 29.
10
Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.在具有高渗性血脑屏障破坏的荷胶质瘤大鼠模型中评估4-硼基-2-(18)F-氟-L-苯丙氨酸用于硼中子俘获治疗的药代动力学
J Nucl Med. 2005 Nov;46(11):1858-65.

引用本文的文献

1
Advantages of FBPA PET in evaluating early response of anti-PD-1 immunotherapy in B16F10 melanoma-bearing mice: Comparison to FDG PET.18F-氟代苯丙氨酸正电子发射断层显像在评估B16F10荷瘤小鼠抗程序性死亡受体1免疫治疗早期反应中的优势:与18F-氟代脱氧葡萄糖正电子发射断层显像的比较
Front Oncol. 2022 Dec 22;12:1026608. doi: 10.3389/fonc.2022.1026608. eCollection 2022.
2
Clinical Use of Radiopharmaceuticals in Boron Neutron Capture Therapy.放射性药物在硼中子俘获疗法中的临床应用。
Nucl Med Mol Imaging. 2022 Jun;56(3):111-113. doi: 10.1007/s13139-022-00739-5. Epub 2022 Mar 14.

本文引用的文献

1
Evaluation of D-isomer of F-FBPA for oncology PET focusing on the differentiation of glioma and inflammation.用于肿瘤正电子发射断层显像(PET)的F-FBPA D-异构体评估:聚焦于胶质瘤与炎症的鉴别诊断
Asia Ocean J Nucl Med Biol. 2020 Spring;8(2):102-108. doi: 10.22038/AOJNMB.2020.47399.1321.
2
4-Borono-2-F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research.用于硼中子俘获疗法导向诊断的4-硼-2-氟-L-苯丙氨酸PET:二十五年研究综述
Ann Nucl Med. 2019 Apr;33(4):223-236. doi: 10.1007/s12149-019-01347-8. Epub 2019 Feb 28.
3
Reliable radiosynthesis of 4-[B]borono-2-[F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis.
用于硼中子俘获治疗导向诊断的具有质量保证的4-[硼]硼酸-2-[氟]氟-L-苯丙氨酸的可靠放射性合成。
Ann Nucl Med. 2018 Aug;32(7):463-473. doi: 10.1007/s12149-018-1268-6. Epub 2018 Jun 5.
4
Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [F]-L-FBPA positron emission tomography in boron neutron capture therapy.使用相同给药剂量和方案比较L-BPA和L-FBPA的药代动力学:一项关于在硼中子俘获治疗中使用[F]-L-FBPA正电子发射断层扫描的诊疗方法的验证研究。
BMC Cancer. 2016 Nov 8;16(1):859. doi: 10.1186/s12885-016-2913-x.
5
Automated electrophilic radiosynthesis of [¹⁸F]FBPA using a modified nucleophilic GE TRACERlab FXFDG.使用改良的亲核型通用电气TRACERlab FXFDG进行[¹⁸F]FBPA的自动化亲电放射性合成。
Appl Radiat Isot. 2015 Oct;104:124-7. doi: 10.1016/j.apradiso.2015.06.034. Epub 2015 Jul 2.
6
FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model.FBPA PET 在癌症硼中子俘获治疗中的应用:在大鼠异种移植模型中预测肿瘤和正常组织中的 (10)B 浓度。
EJNMMI Res. 2014 Dec 20;4(1):70. doi: 10.1186/s13550-014-0070-2. eCollection 2014 Dec.
7
Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer.晚期或复发性头颈癌的硼中子俘获疗法治疗效果
J Radiat Res. 2014 Jan 1;55(1):146-53. doi: 10.1093/jrr/rrt098. Epub 2013 Aug 16.
8
In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).在C6大鼠胶质瘤模型上对¹⁹F标记的硼苯基丙氨酸 - 果糖复合物进行体内¹⁹F磁共振成像(MRI)和¹⁹F磁共振波谱(MRS),以优化硼中子俘获疗法(BNCT)。
Phys Med Biol. 2008 Dec 7;53(23):6979-89. doi: 10.1088/0031-9155/53/23/021. Epub 2008 Nov 12.
9
Boron neutron capture therapy for newly diagnosed glioblastoma.硼中子俘获疗法治疗新诊断的胶质母细胞瘤。
J Radiat Res. 2009 Jan;50(1):51-60. doi: 10.1269/jrr.08043. Epub 2008 Oct 29.
10
Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.用正电子发射断层扫描(PET)研究4-硼-2-[¹⁸F]氟-L-苯丙氨酸在散发性及与神经纤维瘤病2相关的神经鞘瘤和脑膜瘤中的摄取情况。
Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):87-94. doi: 10.1007/s00259-006-0154-y. Epub 2006 Jul 29.